A detailed history of Resurgent Financial Advisors LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Resurgent Financial Advisors LLC holds 3,209 shares of ABBV stock, worth $544,342. This represents 0.37% of its overall portfolio holdings.

Number of Shares
3,209
Previous 2,611 22.9%
Holding current value
$544,342
Previous $447,000 41.61%
% of portfolio
0.37%
Previous 0.27%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$163.84 - $199.33 $97,976 - $119,199
598 Added 22.9%
3,209 $633,000
Q2 2024

Aug 14, 2024

BUY
$154.79 - $180.76 $8,823 - $10,303
57 Added 2.23%
2,611 $447,000
Q1 2024

May 10, 2024

SELL
$159.82 - $182.1 $15,982 - $18,210
-100 Reduced 3.77%
2,554 $465,000
Q4 2023

Feb 09, 2024

SELL
$137.6 - $154.97 $62,470 - $70,356
-454 Reduced 14.61%
2,654 $411,000
Q3 2023

Nov 13, 2023

BUY
$133.59 - $154.65 $935 - $1,082
7 Added 0.23%
3,108 $463,000
Q2 2023

Aug 14, 2023

BUY
$132.51 - $164.9 $19,478 - $24,240
147 Added 4.98%
3,101 $417,000
Q1 2023

May 15, 2023

SELL
$144.61 - $166.54 $554,868 - $639,013
-3,837 Reduced 56.5%
2,954 $470,000
Q4 2022

Feb 14, 2023

SELL
$138.31 - $165.87 $70,814 - $84,925
-512 Reduced 7.01%
6,791 $1.1 Million
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $31,002 - $35,557
231 Added 3.27%
7,303 $980,000
Q2 2022

Aug 15, 2022

BUY
$137.62 - $174.96 $62,479 - $79,431
454 Added 6.86%
7,072 $1.08 Million
Q1 2022

May 16, 2022

BUY
$131.98 - $163.75 $524,356 - $650,578
3,973 Added 150.21%
6,618 $1.07 Million
Q4 2021

May 16, 2022

BUY
$107.43 - $135.93 $284,152 - $359,534
2,645 New
2,645 $358,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $300B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Resurgent Financial Advisors LLC Portfolio

Follow Resurgent Financial Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Resurgent Financial Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Resurgent Financial Advisors LLC with notifications on news.